Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Ostfold Hospital Trust
Sponsor

Ostfold Hospital Trust

Norway P. O. Box 16, 1603 Fredrikstad, Norway

About the sponsor

Clinical research at Ostfold Hospital Trust includes treatment and prevention strategies for venous thromboembolism, with a focus on deep vein thrombosis and pulmonary embolism. The funded studies examine recurrence risk and secondary prevention in patients with prior thrombotic events.

  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Venous Thromboembolism
  • Cardiovascular prevention

These studies reflect an interest in thrombotic disease management within hospital-based internal medicine and acute care settings.

About Specializations

Ostfold Hospital Trust runs clinical trials in conditions such as Major depression, Immune thrombocytopenia, Pulmonary embolism, Venous thrombosis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Immune thrombocytopenia

Recruiting

Study Comparing Avatrombopag and Rituximab for Adults with Immune Thrombocytopenia Not Responding to Corticosteroids

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Avatrombopag
  • Sponsor:Ostfold Hospital Trust

Pulmonary embolism+7

Recruiting

Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rosuvastatin Calcium
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Major depression

Not yet recruiting

A Phase 2 Study of Methylenedioxymethamphetamine‑Assisted Therapy in Young Adults (18‑25) with Chronic Treatment‑Resistant Major Depressive Disorder

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Sponsor:Ostfold Hospital Trust

Major depression+1

Not yet recruiting

A study on ketamine maintenance treatment for patients with treatment-resistant major depression disorder

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Ketamine Hydrochloride
  • Sponsor:Ostfold Hospital Trust

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.